ABVC vs GSK · rev $796.0K vs P/E 13, $103.31B cap
ABVC Biopharma Inc (ABVC) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
GSK does not have a complete income-statement cache yet.
ABVC currently screens at market cap $35.9M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ABVC and GSK stock pages for the full models.
Not investment advice.